Source: Annual Congress 2013 –Pulmonary circulation: treatment
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Galiè, F. Grimminger, E. Grünig, M. Humbert, Z. C. Jing, A. M. Keogh, D. Langleben, L. J. Rubin, M. Ochan Kilama, A. Fritsch, N. Davie, H. A. Ghofrani (Bologna, Milan, Italy; Giessen, Heidelberg, Wuppertal, Germany; Le Kremlin-Bicêtre, France; Shanghai, China; Sydney, Australia; Montreal, Canada; La Jolla, United States Of America). Correlation of improvements in hemodynamics and exercise capacity in patients with PAH: Results from the phase III PATENT-1 study. Eur Respir J 2013; 42: Suppl. 57, 1784

Member's Comments

No comment yet.

Related content which might interest you: Riociguat for the treatment of pulmonary arterial hypertension (PAH): A responder analysis from the phase III PATENT-1 study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 An interim analysis of the phase III riociguat long-term extension study in CTEPH (CHEST-2) Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Hemodynamic effects of different vasodilators in patients with type II pulmonary hypertension (PH) Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Riociguat for the treatment of inoperable CTEPH or persistent/recurrent PH after pulmonary endarterectomy (PEA): A responder analysis from the phase III CHEST-1 study Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Postural change in lung capillary blood volume is less in pulmonary hypertension (PH) compared to healthy controls Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement Year: 2015 Assessment of small airways dysfunction with impulse oscillometry, multiple flow nitric oxide and spirometry in the Wessex severe asthma cohort study Source: International Congress 2015 – Lung function: waiting to exhale... Year: 2015 Nitric oxide metabolite flux during exercise in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Nitric oxide in acute testing in patients with pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Physical training and metabolics of nitric oxide in individuals with idiopathic pulmonary arterial hypertension. Source: International Congress 2019 – Exercise tolerance and its determinants across pathologies Year: 2019 Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1386-1395 Year: 2016 Open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH) Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 The acute and chronic effects of dietry nitrate on exercise tolerance in COPD patients Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 Hyperoxia enhances exercise performance in PAH and CTEPH: Randomized trial Source: International Congress 2016 – Clinic of pulmonary hypertension Year: 2016 Metabolic dysfunction associated with redox imbalance in pulmonary hypertension: Effects of the prolonged sildenafil use Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Change of right heart size and function by long-term therapy with riociguat in patients with PAH and CTEPH Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Nitric oxide from alveolar origin in cirrhotic patients: relationship with pulmonary haemodynamics and potential implications Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Haemodynamic testing in primary pulmonary hypertension - effects of nitric oxide, iloprost and oxygen Source: Eur Respir J 2001; 18: Suppl. 33, 414s Year: 2001 Title: Sublingual glyceryl trinitrate vasoreactivity testing during right heart catheterization for the diagnosis of pulmonary hypertension related to left heart disease Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016